Description
The DoW Autism Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. The award mechanism is offering a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator. Research teams are required to establish and utilize effective and equitable collaborations and partnerships with community members to maximize the translational and impact potential of the proposed research.
• The award supports clinical trials that evaluate promising new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.
• Proposed projects may range from small proof-of-concept trials to large-scale trials to determine efficacy in relevant patient populations.
• Applications are strongly encouraged to address one of the FY26 ARP Clinical Trial Award Areas of Interest.
• The award requires community collaborations to optimize research impact.